Mankind Pharma shareholders and shareholding pattern
NSE: MANKINDBSE: 543904Pharmaceuticals & BiotechnologyMid Cap
Mankind Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2023 · Issue price ₹1,080
Last close ₹2,469.30down ₹20.70 (0.83%)BSE ₹2,461.20
Share price at the NSE close on 29 Oct 2026. Previous close ₹2,490.00.
29 Oct: open ₹2,490.00, high ₹2,509.00, low ₹2,457.50
52-week range of traded prices to 29 Oct 2026
₹1,909.70Low, 23 Mar 2026₹2,642.00High, 29 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,01,993 Cr119th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 45.36
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.30
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,28,54062.4% delivered
Mankind Pharma's shareholding pattern for Sep 2026, filed on 16 Oct 2026, with every filing from Jun 2023: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Mankind Pharma, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters72.62%
- Foreign institutions9.37%
- Indian institutions15.56%
- GovernmentsNone
- Individuals and others2.45%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
| Per cent | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.50% | 76.50% | 76.50% | 74.88% | 74.87% | 74.87% | 72.71% | 72.70% | 72.68% | 72.67% | 72.66% | 72.66% | 72.63% | 72.62% | |
| Indian promoters | 76.50% | 76.50% | 76.50% | 74.88% | 74.87% | 74.87% | 72.71% | 72.70% | 72.68% | 72.67% | 72.66% | 72.66% | 72.63% | 72.62% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 23.50% | 23.50% | 23.50% | 25.12% | 25.13% | 25.13% | 27.29% | 27.30% | 27.32% | 27.33% | 27.34% | 27.34% | 27.37% | 27.38% |
| Shares in issue | 40,05,88,440 | 40,05,88,440 | 40,05,88,440 | 40,05,88,440 | 40,06,35,138 | 40,06,44,138 | 41,25,66,899 | 41,25,78,527 | 41,27,28,748 | 41,27,58,490 | 41,28,05,072 | 41,28,28,328 | 41,29,95,978 | 41,30,45,090 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 36,65,38,439 | 36,05,29,596 | 8,01,17,710 | 8,01,17,710 | 8,01,17,710 | 8,01,17,710 | 0 | 0 | – | – | – | – | – | – |
| Promoters' shares locked in | 30,64,50,146 | 30,64,50,146 | 8,01,17,710 | 8,01,17,710 | 8,01,17,710 | 8,01,17,710 | 0 | 0 | – | – | – | – | – | – |
A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Mankind Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Ramesh Juneja Family Trust (Held in the name of Ramesh Juneja, Managing Trustee), 20.18%. The filing names 79 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Ramesh Juneja Family Trust (Held in the name of Ramesh Juneja, Managing Trustee)Indian companies, trusts and others | 20.18% | 8,33,52,652 |
| Rajeev Juneja Family Trust (Held in the name of Rajeev Juneja, Managing Trustee)Indian companies, trusts and others | 19.35% | 7,99,30,520 |
| Prem Sheetal Family Trust (Held in the name of Arora Family Private Limited, Trustee)Indian companies, trusts and others | 14.95% | 6,17,55,635 |
| SHEETAL ARORAIndividuals and Hindu undivided families | 4.67% | 1,92,77,647 |
| PUJA JUNEJAIndividuals and Hindu undivided families | 2.79% | 1,15,33,906 |
| POONAM JUNEJAIndividuals and Hindu undivided families | 2.56% | 1,05,57,626 |
| ARJUN JUNEJAIndividuals and Hindu undivided families | 1.97% | 81,54,463 |
| RAMESH JUNEJAIndividuals and Hindu undivided families | 1.66% | 68,55,990 |
| RAJEEV JUNEJAIndividuals and Hindu undivided families | 1.57% | 65,00,021 |
| CHANAKYA JUNEJAIndividuals and Hindu undivided families | 0.94% | 38,96,788 |
| EKLAVYA JUNEJAIndividuals and Hindu undivided families | 0.94% | 38,96,788 |
| MISHKA ARORAIndividuals and Hindu undivided families | 0.72% | 29,55,692 |
No promoter shares are reported as pledged.
Largest public holders of Mankind Pharma, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Mankind Pharma
| Holder | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPS TRUST- A/C LIC PENSION FUND SCHEME - STATE GOVProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.65% |
| GOVERNMENT PENSION FUND GLOBALForeign portfolio investors, category I | – | – | – | – | – | 1.11% | 1.54% | 1.52% | 1.63% | 1.68% | 1.65% | 1.53% | 1.29% | 1.06% |
| NPS TRUST - A/C SBI PENSION FUND SCHEME - CORPORATProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | 2.77% | – |
| NPS TRUST- A/C SBI PENSION FUND PVT LTD APY FUND SProvident and pension funds | – | – | – | – | – | – | – | 1.02% | – | – | – | 2.77% | – | – |
| NPS TRUST A/C - LIC PENSION FUND - UPS - CG SCHEMEProvident and pension funds | – | – | – | – | – | – | – | – | – | – | 2.61% | – | – | – |
| NPS TRUST- A/C ICICI PRUDENTIAL PENSION FUND SCHEMProvident and pension funds | – | – | – | – | – | – | – | – | – | 2.08% | – | – | – | – |
| SBI LIFE INSURANCE CO. LTDInsurance companies | – | – | – | – | – | – | – | 1.05% | 1.07% | 1.19% | – | – | – | – |
| NPS TRUST A/C - SBI PENSION FUND - UPS - CG SCHEMEProvident and pension funds | – | – | – | – | – | – | – | – | 1.59% | – | – | – | – | – |
| TATA AIA LIFE INSURANCE COMPANY LIMITED A/C GROUPInsurance companies | – | – | – | – | – | 1.08% | – | – | – | – | – | – | – | – |
| HEMA CIPEF (I) LIMITEDCompanies | 3.63% | 3.63% | 2.22% | 2.22% | 1.62% | – | – | – | – | – | – | – | – | – |
| BEIGE LIMITEDCompanies | 7.46% | 7.46% | 2.99% | – | – | – | – | – | – | – | – | – | – | – |
| CAIRNHILL CIPEF LIMITEDCompanies | 1.74% | 1.74% | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Foreign institutions: GOVERNMENT PENSION FUND GLOBAL 1.06%, −0.23 pts
- Indian institutions: NPS TRUST - A/C SBI PENSION FUND SCHEME - CORPORAT no longer named, from 2.77%; NPS TRUST- A/C LIC PENSION FUND SCHEME - STATE GOV newly named at 2.65%